1. Ginsburg IH. The psychosocial impact of skin disease: an overview. Dermatol Clin 1996; 14: 473-84.
2.
Ring L, Kettis-lindblad Å, Kjellgren KI, et al. Living with skin diseases and topical treatment: patients’ and providers’ perspectives and priorities. J Dermatol Treat 2007; 18: 209-18.
3.
Brieger WR, Oshiname FO, Ososanya OO. Stigma associated with onchocercal skin disease among those affected near the Ofiki and Oyan Rivers in western Nigeria. Social Sci Med 1998; 47: 841-52.
4.
Cortés H, Rojas-Márquez M, Del Prado‐Audelo ML, et al. Alterations in mental health and quality of life in patients with skin disorders: a narrative review. Int J Dermatol 2022; 61: 783-91.
5.
Ahmed A, Leon A, Butler DC, Reichenberg J. Quality-of-life effects of common dermatological diseases. Semin Cutan Med Surg 2013; 32: 101-9.
6.
AlOtaibi HM, AlFurayh NA, AlNooh BM, et al. Quality of life assessment among patients suffering from different dermatological diseases. Saudi Med J 2021; 42: 1195-200.
7.
Taylor SC. Epidemiology of skin diseases in ethnic populations. Dermat Clin 2003; 21: 601-7.
8.
Sampogna F, Picardi A, Chren MM, et al. Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions. Psychosom Med 2004; 66: 620-4.
9.
Abolfotouh MA, Al-Khowailed MS, Suliman WE, et al. Quality of life in patients with skin diseases in Central Saudi Arabia. Int J General Med 2012; 5: 633-42.
10.
Verhoeven EW, Kraaimaat FW, Van De Kerkhof PC, et al. Psychosocial well-being of patients with skin diseases in general practice. J Eur Acad Dermatol Venereol 2007; 21: 662-8.
11.
Barankin B, DeKoven J. Psychosocial effect of common skin diseases. Canad Fam Phys 2002; 48: 712-6.
12.
Evers AW, Duller P, Van De Kerkhof PC, et al. The Impact of Chronic Skin Disease on Daily Life (ISDL): a generic and dermatology-specific health instrument. Br J Dermatol 2008; 158: 101-8.
13.
AlRyalat SA, Malkawi L, Abu-Hassan H, Al-Ryalat N. The impact of skin involvement on the psychological well-being of patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2019; 36: 53-9.
14.
Furue M, Yamazaki S, Jimbow K, et al. Prevalence of dermatological disorders in Japan: a nationwide, cross-sectional, seasonal, multicenter, hospital-based study. J Dermatol 2011; 38: 310-20.
15.
Svensson A, Ofenloch RF, Bruze M, et al. Prevalence of skin disease in a population-based sample of adults from five European countries. Br J Dermatol 2018; 178: 1111-8.
16.
Williams HC. Epidemiology of skin disease. In: Rook’s Textbook of Dermatology. Burns T, Breathnach S, Cox N, et al. (eds.). Wiley 2004; 2-7.
17.
Richard MA, Paul C, Nijsten T, et al.; EADV Burden of Skin Diseases Project Team. Prevalence of most common skin diseases in Europe: a population-based study. J Eur Acad Dermatol Venereol 2022; 36: 1088-96.
18.
Chaturvedi SK, Singh G, Gupta N. Stigma experience in skin disorders: an Indian perspective. Dermatol Clin 2005; 23: 635-42.
19.
Luck-Sikorski C, Roßmann P, Topp J, et al. Assessment of stigma related to visible skin diseases: a systematic review and evaluation of patient‐reported outcome measures. J Eur Acad Dermatol Venereol 2022; 36: 499-525.
20.
Dimitrov D, Szepietowski JC. Stigmatization in dermatology with a special focus on psoriatic patients. Adv Hygiene Exp Med 2017; 71: 1015-22.
21.
Magin P, Adams J, Heading G, Pond D. ‘Perfect skin’, the media and patients with skin disease: a qualitative study of patients with acne, psoriasis and atopic eczema. Australian J Prim Health 2011; 17: 181-5.
22.
Tan JK, Vasey K, Fung KY. Beliefs and perceptions of patients with acne. J Am Acad Dermatol 2001; 44: 439-45.
23.
Green J, Sinclair RD. Perceptions of acne vulgaris in final year medical student written examination answers. Australas J Dermatol 2001; 42: 98-101.
24.
Maspero S, Ebert C, Moser S, et al. The potential of Instagram to reduce stigmatization of people with psoriasis: a randomized controlled pilot study. Acta Dermatovenereol 2023; 103: adv3513.
25.
Furl N. Facial-attractiveness choices are predicted by divisive normalization. Psychol Sci 2016; 27: 1379-87.
26.
Bathe A, Diepgen TL, Matterne U. Subjective illness perceptions in individuals with occupational skin disease: a qualitative investigation. Work 2012; 43: 159-69.
27.
Jankowski M, Goroncy A. Perceptive hierarchy of facial skin lesions: an eye-tracking study. Acta Derm Venereol 2022; 102: adv00799.
28.
Jankowski M, Jasiñski K, P³ocka M, Goroncy A. The aggressive face of melasma: unveiling the influence of upper lip pigmentation on social perception. Adv Dermatol Allergol 2024; 41: 173-80.
29.
Jankowski M, Goroncy A. Anatomical variants of acne differ in their impact on social perception. J Eur Acad Dermatol Venereol 2024; 38: 1628-36.
30.
Augustin M, Eissing L, Elsner P, et al. Perception and image of dermatology in the German general population 2002–2014. J Eur Acad Dermatol Venereol 2017; 31: 2124-30.
31.
Marasigan TP, Lavadia MA, Salas-Walinsundin W. Knowledge, attitude, perception and practices of primary care physicians regarding common dermatological diseases: a cross-sectional study. J Philippine Dermatol Soc 2022; 31: 21-30.
32.
Topal IO, Duman H, Goncu OE, et al. Knowledge, beliefs, and perceptions of Turkish vitiligo patients regarding their condition. An Brasil Dermatol 2016; 91: 770-5.
33.
Richard MA, Joly P, Roy Geffroy B, Taïeb C. Public perception of dermatologists in France: results from a population‐based national survey. J Eur Acad Dermatol Venereol 2019; 33: 1610-5.
34.
Chahine B, Cherfane M, Sakr F, et al. Community pharmacists’ perceptions and role in the management of common dermatological problems in Lebanon: a cross-sectional study. Int J Pharm Pract 2021; 29: 573-9.
35.
Teixeira A, Teixeira M, Herdeiro MT, et al. Knowledge and practices of community pharmacists in topical dermatological treatments. Int J Environ Res Public Health 2021; 18: 2928.
36.
Cho SI, Han B, Hur K, Mun JH. Perceptions and attitudes of medical students regarding artificial intelligence in dermatology. J Eur Acad Dermatol Venereol 2021; 35: e72-3.
37.
Sampogna F, Picardi A, Melchi CF, et al. The impact of skin diseases on patients: comparing dermatologists’ opinions with research data collected on their patients. Br J Dermatol 2003; 148: 989-95.
38.
Germain N, Augustin M, François C, et al. Stigma in visible skin diseases–a literature review and development of a conceptual model. J Eur Acad Dermatol Venereol 2021; 35: 1493-504.
39.
Mahfouz MS, Alqassim AY, Hakami FA, et al. Common skin diseases and their psychosocial impact among Jazan Population, Saudi Arabia: a cross-sectional survey during 2023. Medicina 2023; 59: 1753.
40.
Waseem M, Nickerson AB. Identifying and Addressing Bullying. In: StatPearls. Treasure Island (FL): StatPearls Publishing; December 13, 2023.
41.
Chernyshov PV, Tomas-Aragones L, Manolache L, et al. Bullying in persons with skin diseases. J Eur Acad Dermatol Venereol 2024; 38: 752-60.
42.
Houser AM. Aesthetic Discrimination: The Impact of North American Ideologies of Beauty on the Social Exclusion of People with Skin Disorders, the Healing Power of Special Summer Youth camps, and a Shift to the Social in Biomedical Practice. Temple University; 2011.
43.
Weinberger NA, Mrowietz S, Luck-Sikorski C, et al. Effectiveness of a structured short intervention against stigmatisation in chronic visible skin diseases: results of a controlled trial in future educators. Health Expect 2021; 24: 1790-800.